-- MediSwitch Drug Interactions Import (Part 52/112)
INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(7381, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21828, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31157, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3817, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31628, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7658, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26401, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7860, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(29962, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(8004, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(29563, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7707, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(27391, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26625, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(12156, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(18188, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6026, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28660, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30765, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28327, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26347, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6331, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(29658, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(16838, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(27068, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7897, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15317, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17080, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26729, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3139, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30917, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2629, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31809, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2456, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4464, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(33624, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32365, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20824, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(16785, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28271, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13868, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31292, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24771, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(1074, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24661, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4571, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31788, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32100, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19414, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17698, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26302, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15413, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24522, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30640, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22171, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17384, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17088, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2423, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17787, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(9761, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(29564, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3244, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(1349, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14780, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(5295, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7198, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31691, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(18721, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7694, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(18018, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(12297, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(29351, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30470, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17605, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15428, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14945, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15945, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(10213, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21997, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28166, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31264, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4573, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(23179, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31396, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7287, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20548, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21110, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13873, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31954, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(5921, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17313, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(23180, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6263, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32228, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21426, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14894, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21218, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3332, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30259, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25948, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(26442, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32155, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6895, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4493, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32110, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4172, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25376, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(16910, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24103, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7901, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28666, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30327, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6637, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2226, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13653, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3440, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26893, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13236, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3382, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(33940, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(10519, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22975, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19065, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24516, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(12668, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17568, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7360, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15365, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31138, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19461, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24079, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24984, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15407, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24591, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(33680, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31069, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30425, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32997, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24733, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25536, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26795, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17670, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24533, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(5142, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22327, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31813, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(9593, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25521, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22896, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30641, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(202, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20438, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24532, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28662, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4138, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28595, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28535, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(27499, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19059, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17896, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32061, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3758, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(23660, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22764, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26665, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22110, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20204, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(27767, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(33778, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22195, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28493, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3404, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26324, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32345, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32708, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30351, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20697, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15429, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(544, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32371, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22046, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13298, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4216, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(27868, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25383, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31151, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(24528, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2878, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(16098, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(415, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32076, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20937, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15536, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2811, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25630, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3461, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14339, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(33536, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25797, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(1047, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(24632, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25790, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31627, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(18017, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19990, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13611, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26349, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6798, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22763, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15835, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(912, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14384, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3541, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30615, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19041, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2455, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19288, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13294, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20887, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26919, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19037, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(9589, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(1450, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6780, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7141, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6275, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14439, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(1278, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25412, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2348, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7697, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28913, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21260, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20600, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22305, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30413, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(19334, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32108, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(13816, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(8046, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(3195, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(7741, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15055, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(31819, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26757, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2689, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22974, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2252, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15427, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(20598, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15168, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(16895, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21792, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(155, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(4268, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(22007, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(30336, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(17818, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(26253, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(8208, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(16917, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32892, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14749, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15876, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(23611, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(21995, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(406, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(6089, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(1894, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(27908, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(2692, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(32402, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(28228, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(15050, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(14847, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(29087, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(5252, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(25877, 'pyridostigmine bromide', 'N/A', 'minor', '(7.4)Drugs converted to pantothenic acid (e.g., dexpanthenol): Additive effect. 7.5 Drugs Converted to Pantothenic Acid (e.g., Dexpanthenol) Theoretically, drugs such as dexpanthenol, which are converted to pantothenic acid in vivo, may have additive effects with pyridostigmine by increasing production of acetylcholine.', 'DailyMed'),
(10319, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(10319, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(10319, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(10319, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(10319, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(10319, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(10319, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(10319, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(10319, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(10319, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(10319, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(10319, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(10319, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(10319, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(10319, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(10319, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(10319, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(10319, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(10319, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(10319, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(10319, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(10319, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(10319, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(10319, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(10319, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(10319, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(10319, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(10319, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(10319, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(10319, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(10319, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(10319, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(10319, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(10319, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(10319, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(10319, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(10319, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(10319, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(10319, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(10319, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(10319, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(10319, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(10319, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(10319, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(10319, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(10319, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(10319, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(10319, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(10319, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(10319, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(10319, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(10319, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(10319, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(10319, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(10319, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(10319, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(10319, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(10319, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(10319, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(10319, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(10319, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(10319, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(10319, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(10319, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(10319, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(10319, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(12142, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(12142, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(12142, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(12142, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(12142, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(12142, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(12142, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(12142, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(12142, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(12142, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(12142, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(12142, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(12142, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(12142, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(12142, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12142, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12142, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12142, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(12142, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(12142, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(12142, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(12142, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(12142, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(12142, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(12142, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(12142, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(12142, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12142, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(12142, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(12142, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(12142, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(12142, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(12142, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12142, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(12142, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(12142, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12142, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(12142, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(12142, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(12142, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(12142, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12142, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(12142, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(12142, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(12142, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(12142, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(12142, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(12142, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(12142, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(12142, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(12142, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(12142, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(12142, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(12142, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(12142, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(12142, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(12142, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(12142, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12142, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(12142, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12142, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(12142, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(12142, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(12142, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12142, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(12142, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(12142, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(12142, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(12142, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(12142, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(12142, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(12142, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14187, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(14187, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(14187, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(14187, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(14187, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(14187, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(14187, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(14187, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(14187, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(14187, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(14187, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(14187, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(14187, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(14187, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(14187, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14187, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14187, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(14187, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(14187, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(14187, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(14187, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(14187, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(14187, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(14187, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(14187, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(14187, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14187, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(14187, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(14187, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(14187, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(14187, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(14187, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(14187, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(14187, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(14187, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(14187, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(14187, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(14187, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14187, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(14187, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(14187, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(14187, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(14187, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(14187, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(14187, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(14187, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(14187, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(14187, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(14187, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(14187, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(14187, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(14187, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(14187, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(14187, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(14187, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(14187, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(14187, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(14187, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14187, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(14187, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(14187, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(14187, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(14187, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(14187, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(14187, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(14187, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(19242, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(19242, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(19242, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(19242, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(19242, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(19242, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(19242, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(19242, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(19242, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(19242, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(19242, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(19242, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(19242, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(19242, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(19242, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(19242, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(19242, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(19242, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(19242, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(19242, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(19242, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(19242, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(19242, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(19242, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(19242, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(19242, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(19242, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(19242, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(19242, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(19242, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(19242, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(19242, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(19242, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(19242, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(19242, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(19242, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(19242, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(19242, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(19242, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(19242, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(19242, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(19242, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(19242, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(19242, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(19242, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(19242, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(19242, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(19242, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(19242, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(19242, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(19242, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(19242, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(19242, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(19242, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(19242, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(19242, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(19242, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(19242, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(19242, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(19242, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(19242, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(19242, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(19242, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(19242, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(19242, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(19242, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(31922, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(31922, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(31922, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(31922, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(31922, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(31922, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(31922, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(31922, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(31922, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(31922, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(31922, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(31922, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(31922, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(31922, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(31922, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31922, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31922, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(31922, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(31922, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(31922, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(31922, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(31922, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(31922, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(31922, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(31922, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(31922, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31922, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(31922, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(31922, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(31922, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(31922, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(31922, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31922, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(31922, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(31922, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(31922, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(31922, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(31922, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31922, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(31922, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(31922, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(31922, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(31922, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(31922, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(31922, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(31922, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(31922, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(31922, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(31922, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(31922, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(31922, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(31922, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(31922, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(31922, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(31922, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(31922, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(31922, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(31922, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31922, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(31922, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(31922, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(31922, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(31922, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(31922, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(31922, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(31922, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(9565, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(9565, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(9565, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(9565, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(9565, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(9565, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(9565, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(9565, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(9565, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(9565, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(9565, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(9565, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(9565, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(9565, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(9565, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(9565, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(9565, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(9565, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(9565, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(9565, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(9565, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(9565, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(9565, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(9565, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(9565, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(9565, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(9565, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(9565, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(9565, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(9565, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(9565, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(9565, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(9565, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(9565, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(9565, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(9565, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(9565, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(9565, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(9565, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(9565, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(9565, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(9565, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(9565, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(9565, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(9565, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(9565, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(9565, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(9565, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(9565, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(9565, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(9565, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(9565, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(9565, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(9565, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(9565, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(9565, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(9565, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(9565, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(9565, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(9565, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(9565, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(9565, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(9565, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(9565, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(9565, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(9565, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(26889, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(26889, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(26889, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(26889, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(26889, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(26889, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(26889, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(26889, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(26889, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(26889, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(26889, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(26889, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(26889, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(26889, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(26889, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26889, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26889, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(26889, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(26889, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(26889, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(26889, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(26889, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(26889, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(26889, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(26889, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(26889, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26889, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(26889, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(26889, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(26889, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(26889, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(26889, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(26889, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(26889, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(26889, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(26889, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(26889, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26889, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(26889, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(26889, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(26889, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(26889, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(26889, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(26889, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(26889, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(26889, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(26889, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(26889, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(26889, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(26889, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(26889, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(26889, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(26889, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(26889, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(26889, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(26889, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(26889, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26889, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(26889, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(26889, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(26889, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(26889, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(26889, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(26889, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(26889, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22307, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(22307, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(22307, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(22307, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(22307, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(22307, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(22307, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(22307, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(22307, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(22307, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(22307, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(22307, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(22307, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(22307, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(22307, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(22307, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(22307, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(22307, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(22307, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(22307, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(22307, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(22307, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(22307, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(22307, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(22307, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(22307, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(22307, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(22307, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(22307, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(22307, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(22307, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(22307, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(22307, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(22307, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(22307, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(22307, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(22307, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(22307, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(22307, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(22307, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(22307, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(22307, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(22307, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(22307, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(22307, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(22307, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(22307, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(22307, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(22307, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(22307, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(22307, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(22307, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(22307, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(22307, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(22307, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(22307, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(22307, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(22307, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(22307, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(22307, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(22307, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(22307, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(22307, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(22307, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(22307, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14379, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(14379, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(14379, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(14379, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(14379, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(14379, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(14379, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(14379, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(14379, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(14379, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(14379, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(14379, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(14379, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(14379, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(14379, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14379, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14379, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(14379, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(14379, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(14379, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(14379, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(14379, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(14379, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(14379, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(14379, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(14379, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14379, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(14379, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(14379, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(14379, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(14379, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(14379, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(14379, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(14379, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(14379, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(14379, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(14379, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(14379, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(14379, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(14379, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(14379, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(14379, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(14379, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(14379, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(14379, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(14379, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(14379, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(14379, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(14379, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(14379, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(14379, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(14379, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(14379, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(14379, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(14379, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(14379, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(14379, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(14379, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(14379, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(14379, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(14379, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(14379, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(14379, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(14379, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(14379, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(14379, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(5220, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(5220, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(5220, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(5220, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(5220, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(5220, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(5220, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(5220, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(5220, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(5220, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(5220, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(5220, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(5220, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(5220, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(5220, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5220, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5220, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(5220, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(5220, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(5220, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(5220, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(5220, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(5220, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(5220, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(5220, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(5220, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5220, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(5220, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(5220, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(5220, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(5220, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(5220, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(5220, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(5220, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(5220, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(5220, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(5220, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5220, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(5220, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(5220, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(5220, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(5220, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(5220, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(5220, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(5220, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(5220, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(5220, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(5220, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(5220, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(5220, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(5220, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(5220, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(5220, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(5220, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(5220, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(5220, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(5220, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5220, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(5220, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(5220, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(5220, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(5220, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(5220, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(5220, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(5220, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(27062, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(27062, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(27062, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(27062, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(27062, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27062, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(27062, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(27062, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(27062, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(27062, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(27062, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(27062, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(27062, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(27062, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(27062, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27062, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27062, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(27062, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(27062, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(27062, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(27062, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(27062, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(27062, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(27062, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(27062, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(27062, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27062, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(27062, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(27062, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(27062, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(27062, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(27062, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(27062, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(27062, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(27062, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(27062, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(27062, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(27062, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27062, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(27062, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(27062, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(27062, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(27062, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(27062, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(27062, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(27062, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(27062, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(27062, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(27062, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(27062, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(27062, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(27062, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(27062, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(27062, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(27062, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(27062, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(27062, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(27062, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27062, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(27062, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(27062, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(27062, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(27062, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(27062, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(27062, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(27062, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(27537, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(27537, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(27537, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(27537, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(27537, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(27537, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(27537, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(27537, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(27537, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(27537, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(27537, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(27537, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(27537, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(27537, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(27537, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27537, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27537, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27537, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(27537, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(27537, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(27537, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(27537, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(27537, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(27537, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(27537, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(27537, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(27537, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27537, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(27537, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(27537, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(27537, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(27537, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(27537, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(27537, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(27537, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(27537, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27537, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(27537, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(27537, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(27537, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(27537, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(27537, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(27537, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(27537, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(27537, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(27537, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(27537, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(27537, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(27537, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(27537, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27537, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(27537, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(27537, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(27537, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(27537, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(27537, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(27537, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(27537, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27537, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(27537, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27537, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(27537, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(27537, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(27537, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(27537, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(27537, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(27537, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(27537, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(27537, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(27537, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(27537, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(27537, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(1285, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(1285, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(1285, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(1285, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(1285, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(1285, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(1285, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(1285, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(1285, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(1285, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(1285, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(1285, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(1285, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(1285, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(1285, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1285, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1285, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(1285, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(1285, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(1285, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(1285, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(1285, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(1285, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(1285, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(1285, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(1285, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1285, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(1285, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(1285, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(1285, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(1285, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(1285, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(1285, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(1285, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(1285, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(1285, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(1285, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(1285, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1285, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(1285, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(1285, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(1285, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(1285, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(1285, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(1285, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(1285, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(1285, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(1285, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(1285, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(1285, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(1285, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(1285, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(1285, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(1285, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(1285, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(1285, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(1285, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(1285, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1285, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(1285, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(1285, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(1285, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(1285, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(1285, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(1285, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(1285, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(411, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(411, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(411, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(411, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(411, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(411, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(411, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(411, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(411, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(411, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(411, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(411, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(411, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(411, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(411, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(411, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(411, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(411, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(411, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(411, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(411, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(411, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(411, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(411, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(411, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(411, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(411, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(411, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(411, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(411, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(411, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(411, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(411, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(411, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(411, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(411, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(411, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(411, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(411, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(411, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(411, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(411, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(411, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(411, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(411, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(411, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(411, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(411, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(411, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(411, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(411, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(411, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(411, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(411, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(411, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(411, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(411, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(411, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(411, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(411, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(411, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(411, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(411, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(411, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(411, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(411, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(29113, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(29113, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(29113, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(29113, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(29113, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(29113, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(29113, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(29113, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(29113, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(29113, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(29113, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(29113, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(29113, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(29113, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(29113, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(29113, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29113, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(29113, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(29113, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(29113, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(29113, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(29113, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(29113, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(29113, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(29113, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(29113, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(29113, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(29113, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(29113, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(29113, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(29113, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(29113, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(29113, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(29113, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(29113, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(29113, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(29113, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(29113, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(29113, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(29113, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(29113, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(29113, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(29113, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(29113, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(29113, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(29113, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(29113, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(29113, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(29113, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(29113, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(29113, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(29113, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(29113, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(29113, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(29113, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(29113, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(29113, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(29113, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(29113, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(29113, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(29113, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(29113, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(29113, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(29113, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(29113, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28539, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(28539, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(28539, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(28539, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(28539, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(28539, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(28539, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(28539, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(28539, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(28539, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(28539, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(28539, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(28539, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(28539, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(28539, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28539, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28539, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(28539, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(28539, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(28539, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(28539, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(28539, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(28539, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(28539, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(28539, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(28539, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28539, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(28539, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(28539, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(28539, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(28539, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(28539, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(28539, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(28539, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(28539, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(28539, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(28539, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28539, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(28539, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(28539, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(28539, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(28539, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(28539, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28539, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(28539, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(28539, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(28539, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(28539, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(28539, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(28539, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(28539, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(28539, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(28539, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(28539, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(28539, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(28539, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(28539, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28539, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(28539, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(28539, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(28539, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(28539, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(28539, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(28539, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(28539, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(6828, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(6828, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(6828, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(6828, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(6828, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(6828, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(6828, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(6828, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(6828, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(6828, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(6828, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(6828, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(6828, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(6828, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(6828, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(6828, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(6828, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(6828, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(6828, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(6828, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(6828, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(6828, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(6828, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(6828, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(6828, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(6828, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(6828, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(6828, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(6828, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(6828, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(6828, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(6828, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(6828, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(6828, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(6828, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(6828, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(6828, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(6828, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(6828, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(6828, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(6828, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(6828, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(6828, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(6828, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(6828, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(6828, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(6828, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(6828, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(6828, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(6828, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(6828, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(6828, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(6828, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(6828, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(6828, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(6828, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(6828, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(6828, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(6828, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(6828, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(6828, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(6828, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(6828, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(6828, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(6828, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(24482, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(24482, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(24482, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(24482, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(24482, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(24482, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(24482, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(24482, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(24482, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(24482, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(24482, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(24482, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(24482, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(24482, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(24482, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(24482, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(24482, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(24482, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(24482, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(24482, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(24482, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(24482, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(24482, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(24482, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(24482, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(24482, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(24482, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(24482, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(24482, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(24482, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(24482, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(24482, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(24482, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(24482, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(24482, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(24482, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(24482, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(24482, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(24482, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(24482, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(24482, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(24482, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(24482, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(24482, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(24482, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(24482, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(24482, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(24482, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(24482, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(24482, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(24482, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(24482, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(24482, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(24482, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(24482, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(24482, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(24482, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(24482, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(24482, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(24482, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(24482, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(24482, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(24482, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(24482, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(24482, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(24482, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(30545, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(30545, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(30545, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(30545, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(30545, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(30545, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(30545, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(30545, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(30545, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(30545, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(30545, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(30545, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(30545, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(30545, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(30545, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(30545, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(30545, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(30545, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(30545, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(30545, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(30545, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(30545, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(30545, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(30545, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(30545, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(30545, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(30545, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(30545, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(30545, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(30545, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(30545, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(30545, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(30545, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(30545, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(30545, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(30545, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(30545, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(30545, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(30545, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(30545, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(30545, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(30545, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(30545, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(30545, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(30545, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(30545, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(30545, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(30545, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(30545, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(30545, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(30545, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(30545, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(30545, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(30545, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(30545, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(30545, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(30545, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(30545, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(30545, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(30545, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(30545, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(30545, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(30545, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(30545, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(30545, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(30545, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(2885, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(2885, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(2885, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(2885, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(2885, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(2885, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(2885, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(2885, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(2885, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(2885, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(2885, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(2885, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(2885, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(2885, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2885, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2885, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2885, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2885, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(2885, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(2885, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(2885, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(2885, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(2885, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(2885, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(2885, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(2885, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(2885, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2885, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(2885, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(2885, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(2885, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(2885, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(2885, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2885, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(2885, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(2885, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2885, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(2885, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(2885, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(2885, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(2885, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2885, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(2885, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(2885, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(2885, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(2885, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(2885, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(2885, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(2885, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(2885, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2885, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(2885, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(2885, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(2885, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(2885, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(2885, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(2885, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(2885, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2885, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(2885, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(2885, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(2885, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(2885, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(2885, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2885, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(2885, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(2885, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(2885, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(2885, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(2885, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(2885, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(2885, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13179, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(13179, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(13179, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(13179, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(13179, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(13179, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(13179, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(13179, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(13179, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(13179, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(13179, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(13179, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(13179, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(13179, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(13179, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13179, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13179, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(13179, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(13179, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(13179, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(13179, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(13179, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(13179, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(13179, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(13179, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(13179, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13179, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(13179, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13179, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(13179, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(13179, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13179, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(13179, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(13179, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(13179, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(13179, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(13179, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(13179, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13179, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(13179, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(13179, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(13179, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(13179, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(13179, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(13179, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(13179, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(13179, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(13179, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(13179, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(13179, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(13179, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(13179, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(13179, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(13179, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(13179, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(13179, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(13179, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(13179, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13179, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(13179, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(13179, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(13179, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(13179, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13179, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(13179, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(13179, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(33507, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(33507, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(33507, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(33507, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(33507, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(33507, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(33507, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(33507, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(33507, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(33507, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(33507, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(33507, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(33507, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(33507, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(33507, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(33507, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33507, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(33507, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(33507, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(33507, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(33507, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(33507, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(33507, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(33507, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(33507, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(33507, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33507, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(33507, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(33507, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(33507, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(33507, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(33507, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(33507, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(33507, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(33507, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(33507, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(33507, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(33507, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33507, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(33507, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(33507, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(33507, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(33507, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(33507, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(33507, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(33507, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(33507, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(33507, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(33507, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(33507, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(33507, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(33507, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(33507, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(33507, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(33507, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(33507, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(33507, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(33507, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33507, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(33507, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(33507, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(33507, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(33507, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(33507, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(33507, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(33507, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(31836, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(31836, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(31836, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(31836, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(31836, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(31836, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(31836, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(31836, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(31836, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(31836, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(31836, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(31836, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(31836, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(31836, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(31836, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31836, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31836, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(31836, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(31836, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(31836, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(31836, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(31836, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(31836, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(31836, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(31836, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(31836, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31836, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(31836, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(31836, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(31836, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(31836, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(31836, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(31836, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(31836, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(31836, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(31836, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(31836, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(31836, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(31836, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(31836, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(31836, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31836, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(31836, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(31836, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(31836, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(31836, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(31836, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(31836, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(31836, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(31836, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(31836, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(31836, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(31836, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(31836, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(31836, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(31836, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(31836, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(31836, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(31836, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(31836, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(31836, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(31836, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(31836, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(31836, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(31836, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(31836, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(15611, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(15611, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(15611, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(15611, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(15611, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(15611, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(15611, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(15611, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(15611, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(15611, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(15611, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(15611, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(15611, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(15611, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(15611, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15611, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15611, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(15611, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(15611, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(15611, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(15611, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(15611, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(15611, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(15611, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(15611, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(15611, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15611, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(15611, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(15611, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(15611, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(15611, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(15611, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(15611, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(15611, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(15611, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(15611, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(15611, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(15611, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15611, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(15611, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(15611, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(15611, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(15611, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(15611, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(15611, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(15611, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(15611, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(15611, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(15611, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(15611, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(15611, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(15611, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(15611, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(15611, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(15611, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(15611, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(15611, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(15611, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15611, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(15611, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(15611, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(15611, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(15611, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(15611, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(15611, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(15611, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(17989, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(17989, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(17989, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(17989, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(17989, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(17989, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(17989, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(17989, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(17989, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(17989, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(17989, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(17989, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(17989, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(17989, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(17989, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(17989, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(17989, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(17989, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(17989, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(17989, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(17989, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(17989, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(17989, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(17989, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(17989, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(17989, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(17989, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(17989, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(17989, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(17989, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(17989, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(17989, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(17989, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(17989, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(17989, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(17989, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(17989, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(17989, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(17989, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(17989, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(17989, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(17989, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(17989, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(17989, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(17989, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(17989, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(17989, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(17989, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(17989, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(17989, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(17989, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(17989, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(17989, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(17989, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(17989, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(17989, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(17989, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(17989, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(17989, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(17989, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(17989, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(17989, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(17989, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(17989, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(17989, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(17989, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20817, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(20817, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(20817, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(20817, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(20817, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(20817, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(20817, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(20817, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(20817, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(20817, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(20817, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(20817, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(20817, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(20817, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(20817, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(20817, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(20817, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(20817, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(20817, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(20817, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(20817, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(20817, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(20817, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(20817, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(20817, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(20817, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(20817, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20817, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(20817, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(20817, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(20817, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(20817, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(20817, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(20817, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(20817, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(20817, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(20817, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(20817, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(20817, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(20817, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(20817, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(20817, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(20817, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(20817, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(20817, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(20817, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(20817, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(20817, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(20817, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(20817, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(20817, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(20817, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(20817, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(20817, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(20817, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(20817, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(20817, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(20817, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(20817, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(20817, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(20817, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(20817, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(20817, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(20817, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(20817, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(26579, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(26579, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(26579, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(26579, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(26579, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(26579, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(26579, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(26579, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(26579, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(26579, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(26579, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(26579, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(26579, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(26579, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(26579, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26579, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26579, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(26579, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(26579, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(26579, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(26579, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(26579, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(26579, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(26579, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(26579, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(26579, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26579, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(26579, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(26579, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(26579, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(26579, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(26579, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(26579, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(26579, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(26579, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(26579, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(26579, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(26579, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(26579, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(26579, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(26579, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(26579, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(26579, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(26579, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(26579, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(26579, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(26579, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(26579, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(26579, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(26579, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(26579, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(26579, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(26579, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(26579, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(26579, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(26579, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(26579, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(26579, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(26579, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(26579, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(26579, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(26579, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(26579, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(26579, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(26579, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(26579, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13496, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(13496, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(13496, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(13496, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(13496, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(13496, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(13496, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(13496, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(13496, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(13496, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(13496, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(13496, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(13496, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(13496, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(13496, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13496, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13496, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(13496, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(13496, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(13496, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(13496, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(13496, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(13496, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(13496, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(13496, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(13496, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13496, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(13496, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13496, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(13496, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(13496, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13496, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(13496, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(13496, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(13496, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(13496, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(13496, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(13496, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(13496, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(13496, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(13496, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(13496, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(13496, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(13496, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(13496, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(13496, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(13496, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(13496, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(13496, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(13496, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(13496, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(13496, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(13496, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(13496, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(13496, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(13496, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(13496, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(13496, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(13496, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(13496, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(13496, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(13496, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(13496, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13496, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(13496, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(13496, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(33057, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(33057, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(33057, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(33057, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(33057, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(33057, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(33057, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(33057, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(33057, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(33057, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(33057, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(33057, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(33057, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(33057, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(33057, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33057, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33057, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(33057, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(33057, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(33057, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(33057, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(33057, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(33057, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(33057, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(33057, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(33057, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33057, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(33057, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(33057, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(33057, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(33057, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(33057, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(33057, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(33057, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(33057, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(33057, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(33057, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(33057, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(33057, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(33057, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(33057, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(33057, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(33057, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(33057, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(33057, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(33057, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(33057, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(33057, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(33057, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(33057, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(33057, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(33057, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(33057, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(33057, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(33057, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(33057, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(33057, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(33057, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(33057, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(33057, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(33057, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(33057, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(33057, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(33057, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(33057, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(5959, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(5959, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(5959, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(5959, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(5959, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(5959, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(5959, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(5959, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(5959, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(5959, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(5959, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(5959, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(5959, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(5959, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(5959, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5959, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5959, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(5959, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(5959, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(5959, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(5959, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(5959, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(5959, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(5959, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(5959, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(5959, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5959, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(5959, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(5959, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(5959, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(5959, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(5959, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(5959, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(5959, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(5959, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(5959, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(5959, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(5959, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(5959, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5959, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(5959, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(5959, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(5959, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(5959, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(5959, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(5959, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(5959, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(5959, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(5959, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(5959, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(5959, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(5959, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(5959, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(5959, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(5959, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(5959, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(5959, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(5959, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(5959, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(5959, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(5959, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(5959, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(5959, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(5959, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(5959, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(5959, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(16224, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(16224, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(16224, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(16224, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(16224, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(16224, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(16224, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(16224, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(16224, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(16224, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(16224, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(16224, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(16224, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(16224, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(16224, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(16224, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(16224, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(16224, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(16224, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(16224, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(16224, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(16224, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(16224, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(16224, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(16224, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(16224, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(16224, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(16224, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(16224, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(16224, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(16224, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(16224, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(16224, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(16224, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(16224, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(16224, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(16224, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(16224, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(16224, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(16224, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(16224, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(16224, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(16224, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(16224, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(16224, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(16224, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(16224, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(16224, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(16224, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(16224, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(16224, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(16224, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(16224, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(16224, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(16224, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(16224, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(16224, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(16224, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(16224, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(16224, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(16224, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(16224, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(16224, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(16224, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(16224, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(16224, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(21627, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(21627, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(21627, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(21627, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(21627, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(21627, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(21627, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(21627, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(21627, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(21627, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(21627, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(21627, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(21627, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(21627, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(21627, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(21627, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(21627, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(21627, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(21627, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(21627, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(21627, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(21627, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(21627, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(21627, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(21627, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(21627, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(21627, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(21627, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(21627, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(21627, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(21627, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(21627, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(21627, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(21627, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(21627, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(21627, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(21627, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(21627, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(21627, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(21627, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(21627, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(21627, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(21627, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(21627, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(21627, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(21627, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(21627, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(21627, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(21627, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(21627, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(21627, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(21627, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(21627, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(21627, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(21627, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(21627, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(21627, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(21627, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(21627, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(21627, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(21627, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(21627, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(21627, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(21627, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(21627, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(21627, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(23197, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(23197, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(23197, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(23197, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(23197, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(23197, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(23197, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(23197, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(23197, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(23197, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(23197, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(23197, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(23197, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(23197, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(23197, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(23197, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(23197, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(23197, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(23197, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(23197, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(23197, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(23197, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(23197, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(23197, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(23197, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(23197, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(23197, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(23197, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(23197, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(23197, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(23197, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(23197, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(23197, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(23197, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(23197, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(23197, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(23197, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(23197, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(23197, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(23197, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(23197, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(23197, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(23197, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(23197, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(23197, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(23197, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(23197, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(23197, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(23197, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(23197, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(23197, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(23197, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(23197, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(23197, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(23197, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(23197, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(23197, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(23197, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(23197, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(23197, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(23197, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(23197, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(23197, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(23197, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(23197, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(23197, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28558, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(28558, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(28558, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(28558, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(28558, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(28558, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(28558, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(28558, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(28558, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(28558, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(28558, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(28558, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(28558, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(28558, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(28558, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28558, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28558, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(28558, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(28558, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(28558, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(28558, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(28558, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(28558, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(28558, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(28558, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(28558, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28558, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(28558, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(28558, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(28558, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(28558, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(28558, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(28558, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(28558, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(28558, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(28558, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(28558, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(28558, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(28558, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(28558, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(28558, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(28558, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(28558, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(28558, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(28558, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(28558, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(28558, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(28558, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(28558, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(28558, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28558, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(28558, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(28558, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(28558, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(28558, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(28558, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(28558, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(28558, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(28558, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(28558, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(28558, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(28558, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(28558, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(28558, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(28558, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(28558, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(15609, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(15609, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(15609, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(15609, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(15609, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(15609, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(15609, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(15609, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(15609, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(15609, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(15609, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(15609, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(15609, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(15609, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(15609, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15609, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15609, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(15609, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(15609, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(15609, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(15609, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(15609, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(15609, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(15609, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(15609, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(15609, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15609, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(15609, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(15609, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(15609, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(15609, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(15609, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(15609, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(15609, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(15609, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(15609, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(15609, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(15609, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(15609, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(15609, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(15609, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(15609, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(15609, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(15609, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(15609, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(15609, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(15609, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(15609, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(15609, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(15609, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(15609, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(15609, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(15609, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(15609, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(15609, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(15609, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(15609, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(15609, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(15609, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(15609, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(15609, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(15609, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(15609, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(15609, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(15609, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(1544, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(1544, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(1544, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(1544, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(1544, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(1544, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(1544, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(1544, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(1544, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(1544, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(1544, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(1544, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(1544, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(1544, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(1544, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1544, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1544, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(1544, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(1544, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(1544, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(1544, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(1544, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(1544, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(1544, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(1544, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(1544, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1544, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(1544, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(1544, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(1544, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(1544, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(1544, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(1544, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(1544, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(1544, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(1544, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(1544, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(1544, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(1544, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(1544, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(1544, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(1544, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(1544, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(1544, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(1544, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(1544, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(1544, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(1544, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(1544, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(1544, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(1544, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(1544, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(1544, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(1544, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(1544, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(1544, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(1544, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(1544, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(1544, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(1544, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(1544, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(1544, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(1544, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(1544, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(1544, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(1544, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(2322, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(2322, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(2322, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(2322, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(2322, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(2322, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(2322, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(2322, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(2322, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(2322, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(2322, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(2322, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(2322, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(2322, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(2322, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2322, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2322, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(2322, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(2322, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(2322, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(2322, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(2322, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(2322, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(2322, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(2322, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(2322, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2322, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(2322, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(2322, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(2322, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(2322, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(2322, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(2322, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(2322, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(2322, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(2322, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(2322, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(2322, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(2322, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(2322, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(2322, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(2322, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(2322, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(2322, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(2322, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(2322, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(2322, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(2322, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(2322, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(2322, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(2322, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(2322, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(2322, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(2322, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(2322, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(2322, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(2322, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(2322, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(2322, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(2322, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(2322, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed'),
(2322, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(2322, 'tipranavir', 'N/A', 'minor', 'A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin).', 'DailyMed'),
(2322, 'migalastat hydrochloride', 'N/A', 'minor', '(7.1) 7.1 Effect of Other Drugs on GALAFOLD Co-administration of GALAFOLD with caffeine decreases migalastat AUC and Cmax [see Clinical Pharmacology (12.3)] which may reduce GALAFOLD efficacy. Avoid co-administration of GALAFOLD with caffeine at least 2 hours before and 2 hours after taking GALAFOLD [see Dosage and Administration (2.2)].', 'DailyMed'),
(2322, 'maribavir', 'N/A', 'major', '7.4 Drugs without Clinically Significant Interactions with LIVTENCITY No clinically significant interactions were observed in clinical drug-drug interaction studies of LIVTENCITY and ketoconazole, antacid, caffeine, warfarin, voriconazole, dextromethorphan, or midazolam [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(12251, 'trovafloxacin mesylate', 'N/A', 'moderate', 'Patients should also be monitored for evidence of bleeding.Minor pharmacokinetic interactions without clinical significance have been observed with co-administration of TROVAN Tablets with caffeine, omeprazole and calcium carbonate.', 'DailyMed'),
(12251, 'lomefloxacin hydrochloride', 'N/A', 'major', 'Caffeine Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd. This did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite, paraxanthine. No data are available on potential interactions in individuals who consume greater than 200 mg of caffeine per day or in those, such as the geriatric population, who are generally believed to be more susceptible to the development of drug-induced CNS-related adverse effects.', 'DailyMed'),
(12251, 'dipyridamole', 'N/A', 'minor', 'Drug Interactions: Oral maintenance theophylline and other xanthine derivatives such as caffeine may abolish the coronary vasodilatation induced by intravenous dipyridamole administration.', 'DailyMed'),
(12251, 'theophyllin, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledlomefloxacin amoxicillinmebendazole ampicillin, with or without sulbactammedroxyprogesterone atenololmethylprednisolone azithromycinmetronidazole caffeine, dietary ingestionmetoprolol cefaclornadolol co-trimoxazole (trimethoprim and sulfamethoxazole)nifedipine diltiazemnizatidine dirithromycinnorfloxacin enfluraneofloxacin famotidineomeprazole felodipineprednisone, prednisolone finasterideranitidine hydrocortisonerifabutin isofluraneroxithromycin isoniazidsorbitol (purgative doses do not inhibit theophylline absorption) isradipinesucralfate influenza vaccineterbutaline, systemic ketoconazoleterfenadine tetracycline ', 'DailyMed'),
(12251, 'theophylline, anhydrous', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, systemic and inhaledfelodipinefinasteridenizatidinenorfloxacin amoxicillinhydrocortisoneofloxacin ampicillin, with or without sulbactamisofluraneisoniazidomeprazoleprednisone, prednisolone atenololisradipineranitidine azithromycininfluenza vaccinerifabutin caffeine, dietary ingestionketoconazolelomefloxacinroxithromycinsorbitol cefaclormebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole)medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazemmetronidazolesucralfate dirithromycinmetoprololterbutaline, systemic enfluranenadololterfenadine famotidinenifedipinetetracycline tocainide', 'DailyMed'),
(12251, 'butalbital, aspirin, and caffeine', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, and caffeine capsules may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing an additive effect, if dosage of butalbital, aspirin, and caffeine capsules exceed maximum recommended daily dose.6-mercaptopuri', 'DailyMed'),
(12251, 'acetaminophen, caffeine and dihydrocodeine bitartrate', 'N/A', 'minor', 'Caffeine-Drug Interactions Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(12251, 'butalbital, aspirin, caffeine and codeine phosphate', 'N/A', 'minor', 'Drug Interactions The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors.In patients receiving concomitant corticosteroids and chronic use of aspirin, withdrawal of corticosteroids may result in salicylism because corticosteroids enhance renal clearance of salicylates and their withdrawal is followed by return to normal rates of renal clearance.Butalbital, aspirin, caffeine and codeine may enhance the effects of:Oral anticoagulants, causing bleeding by inhibiting prothrombin formation in the liver and displacing anticoagulants from plasma protein binding sites.Oral antidiabetic agents and insulin, causing hypoglycemia by contributing to an additive effect, if dosage of this product exceeds maximum recommended daily dosage.6-mercaptopurine and methotrexate, caus', 'DailyMed'),
(12251, 'mexiletine hydrochloride', 'N/A', 'minor', 'An appropriate adjustment in theophylline dose should be considered.Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine.', 'DailyMed'),
(12251, 'venlafaxine hydrochloride', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(12251, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(12251, 'tolterodine tartrate', 'N/A', 'minor', '7.3 Other interactionsNo clinically relevant interactions have been observed when tolterodine was co-administered with warfarin, with a combined oral contraceptive drug containing ethinyl estradiol and levonorgestrel, or with diuretics [see CLINICAL PHARMACOLOGY (12.3) ] 7.4 Other drugs metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [see CLINICAL PHARMACOLOGY (12.3) ].', 'DailyMed'),
(12251, 'pantoprazole sodium', 'N/A', 'minor', 'Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin (see below), midazolam, clarithromycin, metronidazole, or amoxicillin.', 'DailyMed'),
(12251, 'ciprofloxacin', 'N/A', 'minor', 'Ciprofloxacin also decreases caffeine clearance and inhibits the formation of paraxanthine after caffeine administration.', 'DailyMed'),
(12251, 'duloxetine hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'butalbital, acetaminophen, and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12251, 'butalbital and acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12251, 'ofloxacin', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(12251, 'theophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled mebendazole amoxicillin medroxyprogesterone ampicillin, with or without sulbactam methylprednisolone metronidazole atenolol metoprolol azithromycin nadolol caffeine, dietary ingestion nifedipine cefaclor nizatidine co-trimoxazole (trimethoprim and sulfamethoxazole) norfloxacin ofloxacin diltiazem omeprazole dirithromycin prednisone, prednisolone enflurane ranitidine famotidine rifabutin felodipine roxithromycin finasteride sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin', 'DailyMed'),
(12251, 'butalbital, acetaminophen and caffeine', 'N/A', 'minor', 'Butalbital, Acetaminophen and Caffeine Tablets may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression', 'DailyMed'),
(12251, 'adenosine', 'N/A', 'minor', 'The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.', 'DailyMed'),
(12251, 'butalbital, aspirin and caffeine', 'N/A', 'minor', 'Drug Interactions: Patients receiving narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with Butalbital, Aspirin, and Caffeine Tablets may exhibit additive CNS depressant effects.', 'DailyMed'),
(12251, 'terbinafine hydrochloride', 'N/A', 'minor', 'Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(12251, 'dihydrocodeine bitartrate, acetaminophen and caffeine', 'N/A', 'minor', 'Caffeine-Drug Interactions: Caffeine may enhance the cardiac inotropic effects of beta-adrenergic stimulating agents. Coadministration of caffeine and disulfiram may lead to a substantial decrease in caffeine clearance. Caffeine may increase the metabolism of other drugs such as phenobarbital and aspirin.', 'DailyMed'),
(12251, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Some quinolones, including ciprofloxacin, have also been shown to interfere with the metabolism of caffeine. This may lead to reduced clearance of caffeine and a prolongation of its serum half-life.', 'DailyMed'),
(12251, 'theophylline anhydrous, choline', 'N/A', 'major', 'Drugs that have been documented not to interact with theophylline or drugs that produce no clinically significant interaction with theophylline.* albuterol, famotidine nizatidine systemic and inhaled felodipine norfloxacin amoxicillin finasteride ofloxacin ampicillin, hydrocortisone omeprazole with or without isoflurane prednisone, prednisolone sulbactam isoniazid ranitidine atenolol isradipine rifabutin azithromycin influenza vaccine roxithromycin caffeine, ketoconazole sorbitol dietary digestion lomefloxacin (purgative doses do not cefaclor mebendazole inhibit theophylline co-trimoxazole medroxyprogesterone absorption) (trimethoprim and methylprednisolone sucralfate sulfamethoxazole) metronidazole terbutaline, systemic diltiazem metoprolol terfenadine dirithromycin nadolol tetracycline e', 'DailyMed'),
(12251, 'butalbital, acetaminophen, caffeine and codeine phosphate', 'N/A', 'minor', 'Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may enhance the effects of: - Other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12251, 'armodafinil', 'N/A', 'minor', 'Chronic administration of NUVIGIL at 250 mg did not affect the pharmacokinetics of caffeine (200 mg), a probe substrate for CYP1A2 activity.', 'DailyMed'),
(12251, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(12251, 'theophylline anhydrous', 'N/A', 'moderate', 'PRECAUTIONS, Drug Interactions albuterol, systemic and inhaled felodipinefinasteride nizatidinenorfloxacin amoxicillin hydrocortisone ofloxacin ampicillin, with or without sulbactam isoflurane isoniazid omeprazole prednisone, prednisolone atenolol isradipine ranitidine azithromycin influenza vaccine rifabutin caffeine, dietary ingestion ketoconazo lelomefloxacin roxithromycin sorbitol cefaclor mebendazole (purgative doses do not co-trimoxazole (trimethoprim and sulfamethoxazole) medroxyprogesteronemethylprednisolone inhibit theophylline absorption) diltiazem metronidazole sucralfate dirithromycin metoprolol terbutaline, systemic enflurane nadolol terfenadine famotidine nifedipine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum t', 'DailyMed'),
(12251, 'ergotamine tartrate and caffeine', 'N/A', 'minor', 'Ergotamine tartrate and caffeine should not be administered with other vasoconstrictors. The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine by blocking the vasodilating property of epinephrine.', 'DailyMed'),
(12251, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(12251, 'duloxetine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'terbinafine', 'N/A', 'minor', '7 DRUG INTERACTIONS Terbinafine is an inhibitor of CYP4502D6 isozyme and has an effect on metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(12251, 'clozapine', 'N/A', 'moderate', '[see Dosage and Administration (2.6), Clinical Pharmacology (12.3)] Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.', 'DailyMed'),
(12251, 'duloxetin hydrochloride', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'quinidine gluconate', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine.', 'DailyMed'),
(12251, 'venlafaxine', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(12251, 'regadenoson', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of LEXISCAN (7.1, 12.2). 7.1 Effects of Other Drugs on LEXISCAN Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(12251, 'caffeine citrate', 'N/A', 'major', 'Drug Interactions Cytochrome P450 1A2 (CYP1A2) is known to be the major enzyme involved in the metabolism of caffeine. Therefore, caffeine has the potential to interact with drugs that are substrates for CYP1A2, inhibit CYP1A2, or induce CYP1A2. Few data exist on drug interactions with caffeine in preterm neonates.', 'DailyMed'),
(12251, 'butalbital, acetaminophen, and caffeine capsules', 'N/A', 'minor', 'Butalbital, acetaminophen, and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.', 'DailyMed'),
(12251, 'aminophylline', 'N/A', 'minor', 'Albuterol, systemic and inhaled amoxicillin ampicillin, with or without sulbactam atenolol azithromycin caffeine, dietary ingestion cefaclor co-trimoxazole (trimethoprim and sulfamethoxazole) diltiazem dirithromycin enflurane famotidine felodipine finasteride hydrocortisone isoflurane isoniazid isradipine influenza vaccine ketoconazole lomefloxacin mebendazole medroxyprogesterone methylprednisolone metronidazole metoprolol nadolol nifedipine nizatidine norfloxacin ofloxacin omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinic', 'DailyMed'),
(12251, 'butalbital, acetaminophen, caffeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Table 1: Clinically Significant Drug Interactions with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Acetaminophen, Caffeine, and Codeine', 'DailyMed'),
(12251, 'tolcapone', 'N/A', 'minor', 'No relevant interactions with substrates for CYP 2A6 (warfarin), CYP 1A2 (caffeine), CYP 3A4 (midazolam, terfenadine, cyclosporine), CYP 2C19 (S-mephenytoin) and CYP 2D6 (desipramine) were observed in vitro.', 'DailyMed'),
(12251, 'deferasirox', 'N/A', 'minor', '7.4Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(12251, 'terbinafine tablets 250 mg', 'N/A', 'minor', 'Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. Terbinafine decreases the clearance of caffeine by 19%.', 'DailyMed'),
(12251, 'acetaminophen, caffeine, dihydrocodeine bitartrate', 'N/A', 'moderate', 'Drug Interactions CYP2D6 Inhibitors Dihydrocodeine in Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is metabolized by CYP2D6 to form dihydromorphine. The concomitant use of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate and CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, paroxetine bupropion) can increase the plasma concentration of dihydrocodeine, but can decrease the plasma concentration of active metabolite dihydromorphine which could result in reduced analgesic efficacy or symptoms of opioid withdrawal, particularly when an inhibitor is added after a stable dose of Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate is achieved. If concomitant use with a CYP2D6 inhibitor is necessary or if a CYP2D6 inhibitor is discontinued after concomitant use, consider dosage ad', 'DailyMed'),
(12251, 'tranylcypromine', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine C lass of F ood or Beverage Tyramine-Rich Foods and Beverages to Avoid Acce ptable Foods and Dr inks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odor, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ri', 'DailyMed'),
(12251, 'deferasirox oral', 'N/A', 'minor', '7.4 Agents Metabolized by CYP1A2 Deferasirox inhibits CYP1A2 resulting in an increase in CYP1A2 substrate (e.g., alosetron, caffeine, duloxetine, melatonin, ramelteon, tacrine, theophylline, tizanidine) concentration when these drugs are coadministered.', 'DailyMed'),
(12251, 'duloxetine and lidocaine', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'tranylcypromine sulfate', 'N/A', 'major', 'Table 5: Foods and Beverages with and without Significant Amounts of Tyramine Class of Food or Beverage Tyramine-Rich Foods and Beverages to Avoid Acceptable Foods and Drinks, Containing No or Little Tyramine Meat, Poultry, and Fish Air dried, aged and fermented meats, sausages and salamis (including cacciatore, hard salami and mortadella); pickled herring; and any spoiled or improperly stored meat, poultry, and fish (e.g., foods that have undergone changes in coloration, odo, or become moldy); spoiled or improperly stored animal livers Fresh meat, poultry, and fish, including fresh processed meats (e.g., lunch meats, hot dogs, breakfast sausage, and cooked sliced ham) Vegetables Broad bean pods (fava bean pods) All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta', 'DailyMed'),
(12251, 'quinidine sulfate tablet', 'N/A', 'major', 'Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, diltiazem, felodipine, omeprazole, or quinine.', 'DailyMed'),
(12251, 'venlafaxine hydrochloride, extended release', 'N/A', 'minor', 'This finding was confirmed in vivo by a clinical drug interaction study in which venlafaxine did not inhibit the metabolism of caffeine, a CYP1A2 substrate.', 'DailyMed'),
(12251, 'lexiscan(r) (regadenoson)', 'N/A', 'minor', '7.1 Effects of Other Drugs on LEXISCAN  Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of LEXISCAN [see Clinical Pharmacology ( 12-12.2) and Patient Counseling Information ( 17)].', 'DailyMed'),
(12251, 'stiripentol', 'N/A', 'minor', 'Because of potential drug-drug interactions, consider dose adjustment of CYP1A2 substrates (e.g., theophylline, caffeine), CYP2B6 substrates (e.g., sertraline, thiotepa), and CYP3A4 substrates (e.g., midazolam, triazolam, quinidine), as clinically appropriate, when administered concomitantly with DIACOMIT.', 'DailyMed'),
(12251, 'ciprofolxacin', 'N/A', 'moderate', 'Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(12251, 'butalbital, aspirin, cafeine, and codeine phosphate', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Table 1 includes clinically significant drug interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP. Table 1: Clinically Significant Drug Interactions with Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP Inhibitors of CYP3A4 Clinical Impact: The concomitant use of Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules, USP with CYP3A4 inhibitors may result in an increase in codeine plasma concentrations with subsequently greater metabolism by cytochrome CYP2D6, resulting in greater morphine levels, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression, particularly when an inhibitor is added after a stable dose of Butalbital, Aspirin, Caffeine, and Codeine Phosphat', 'DailyMed'),
(12251, 'duloxetine delayed-release capsules', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'ciprofloxacin tablets', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(12251, 'duloxetine hcl', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'ciprofloxacin hcl', 'N/A', 'moderate', 'Duloxetine Avoid Use Five-fold increase in duloxetine exposure If unavoidable, monitor for duloxetine toxicity Caffeine/Xanthine Derivatives Use with caution Reduced clearance resulting in elevated levels and prolongation of serum half-life Ciprofloxacin inhibits the formation of paraxanthine after caffeine administration (or pentoxifylline containing products).', 'DailyMed'),
(12251, 'enasidenib mesylate', 'N/A', 'minor', 'Consider reducing the frequency of caffeine intake from various food and beverages in a 24 hour period while taking IDHIFA because IDHIFA may increase the effect of caffeine in patients who are sensitive to it.', 'DailyMed'),
(12251, 'ofloxacin ophthalmic solution usp, 0.3%', 'N/A', 'minor', 'However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.', 'DailyMed'),
(12251, 'duloxetine d/r', 'N/A', 'minor', 'Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed.', 'DailyMed'),
(12251, 'regadenoson anhydrous', 'N/A', 'minor', 'Methylxanthines, e.g., caffeine, aminophylline and theophylline, interfere with the activity of regadenoson injection (7.1, 12.2). 7.1 Effects of Other Drugs on Regadenoson Injection Methylxanthines (e.g., caffeine, aminophylline and theophylline) are non-specific adenosine receptor antagonists that interfere with the vasodilation activity of regadenoson injection [see Clinical Pharmacology (12.2) and Patient Counseling Information (17)].', 'DailyMed'),
(12251, 'pregabalin', 'N/A', 'minor', 'Therefore, an increase in the metabolism of coadministered CYP1A2 substrates (e.g., theophylline, caffeine) or CYP3A4 substrates (e.g., midazolam, testosterone) is not anticipated.', 'DailyMed'),
(12251, 'tolterodine', 'N/A', 'minor', '7.4 Other Drugs Metabolized by Cytochrome P450 Isoenzymes In vivo drug-interaction data show that tolterodine immediate release does not result in clinically relevant inhibition of CYP1A2, 2D6, 2C9, 2C19, or 3A4 as evidenced by lack of influence on the marker drugs caffeine, debrisoquine, S-warfarin, and omeprazole [ see CLINICAL PHARMACOLOGY ( 12.3) ].', 'DailyMed'),
(12251, 'nicotine', 'N/A', 'minor', 'May Require a Decrease in Dose at Cessation of Smoking Possible Mechanism Acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol, or other beta-blockers, theophylline Deinduction of hepatic enzymes on smoking cessation.', 'DailyMed');

